Taxane‐based chemohormonal therapy for metastatic hormone‐sensitive prostate cancer

BACKGROUND: There has been considerable development in the treatment of advanced prostate cancer over the last decade. A number of agents, including docetaxel, cabazitaxel, abiraterone acetate, enzalutamide and sipuleucel‐T, have been reported to improve outcomes in men with castration‐resistant dis...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Cochrane Database Syst Rev
Asıl Yazarlar: Sathianathen, Niranjan J, Philippou, Yiannis A, Kuntz, Gretchen M, Konety, Badrinath R, Gupta, Shilpa, Lamb, Alastair D, Dahm, Philipp
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: John Wiley & Sons, Ltd 2018
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6516883/
https://ncbi.nlm.nih.gov/pubmed/30320443
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD012816.pub2
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller